Cargando…

Prevalence of oral corticosteroid use in the German severe asthma population

AIMS: We investigated the prevalence of severe asthma, its comorbidities, and especially the use of oral corticosteroid (OCS) therapy in patients with severe asthma. METHODS: Pooled data from 3 961 429 patients insured (with statutory health insurance) during the year 2015 were analysed. Prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taube, Christian, Bramlage, Peter, Hofer, Annette, Anderson, Dörte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819991/ https://www.ncbi.nlm.nih.gov/pubmed/31687373 http://dx.doi.org/10.1183/23120541.00092-2019

Ejemplares similares

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Rational oral corticosteroid use in adult severe asthma: A narrative review
por: Chung, Li Ping, et al.
Publicado: (2019)

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
por: Domingo, Christian, et al.
Publicado: (2023)

Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma
por: Ramsahai, J. Michael, et al.
Publicado: (2020)

Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype
por: Knarborg, Malene, et al.
Publicado: (2014)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
por: Graff, S., et al.
Publicado: (2020)

A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2017)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
por: Silver, Jared, et al.
Publicado: (2020)

Climate Change to Blame in Severe Oral Corticosteroid-Dependent Asthma? A Case Report
por: Huang, Chunrong, et al.
Publicado: (2020)

Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
por: Tanaka, Akihiko, et al.
Publicado: (2023)

Using biomarkers to adjust corticosteroid dose in patients with severe asthma
por: Jones, Thomas L.
Publicado: (2021)

How can we minimise the use of regular oral corticosteroids in asthma?
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
por: Haughney, John, et al.
Publicado: (2023)

Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
por: Suhling, Hendrik, et al.
Publicado: (2023)

Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma
por: Cardoso‐Vigueros, Carlos, et al.
Publicado: (2022)

Unmet Need for Oral Corticosteroids Use and Exacerbations of Asthma in Primary Care in Taiwan
por: Chen, Yen-Wen, et al.
Publicado: (2022)

Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia
por: Hew, Mark, et al.
Publicado: (2020)

Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses
por: Almonacid, Carlos, et al.
Publicado: (2023)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Prevalence of obesity in primary care using different anthropometric measures – Results of the German Metabolic and Cardiovascular Risk Project (GEMCAS)
por: Hauner, Hans, et al.
Publicado: (2008)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study
por: Choi, Hayoung, et al.
Publicado: (2020)

cFLIP expression is altered in severe corticosteroid-resistant asthma
por: Lazarev, Dennis, et al.
Publicado: (2014)

Bronchial angiogenesis in horses with severe asthma and its response to corticosteroids
por: Millares‐Ramirez, Esther M., et al.
Publicado: (2021)

Prescription Patterns of Oral Corticosteroids for Asthma Treatment and Related Asthma Phenotypes in University Hospitals in Korea
por: Kwon, Jae-Woo, et al.
Publicado: (2022)

Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment From the Korean Severe Asthma Registry (KoSAR)
por: Lee, Ji-Hyang, et al.
Publicado: (2022)

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
por: Tran, Trung N., et al.
Publicado: (2020)

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma
por: Haughney, John, et al.
Publicado: (2023)

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use
por: Maselli, Diego Jose, et al.
Publicado: (2018)

Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2011)

Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study
por: Reinke, Stacey N., et al.
Publicado: (2022)

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
por: Korn, Stephanie, et al.
Publicado: (2023)

Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan
por: Wang, Wei-Chen, et al.
Publicado: (2017)

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
por: Casale, Thomas B., et al.
Publicado: (2022)

Local adverse effects associated with the use of inhaled corticosteroids in patients with moderate or severe asthma
por: Pinto, Charleston Ribeiro, et al.
Publicado: (2013)

Electronic health record-based assessment of oral corticosteroid use in a population of primary care patients with asthma: an observational study
por: Allen-Ramey, Felicia C, et al.
Publicado: (2013)

Use of asthma drugs and prevalence of molar incisor hypomineralization
por: Wogelius, Pia, et al.
Publicado: (2020)

Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden
por: Ekström, Magnus, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o71i5ns81ia1t7dtqa7qo7okje